Innate Immunotherapeutics Limited

Introduction

  1. The Panel, Bruce Cowley, Rodd Levy (sitting President) and Ron Malek declined to conduct proceedings on an application by Mr James Wheeldon in relation to the affairs of Innate Immunotherapeutics Limited. The Application submitted, based on publicly available information, that there was an available inference that a director and shareholder of Innate may be associated with family members and other shareholders and may have obtained effective control of Innate in contravention of section 606 of the Corporations Act 2001 (Cth).

Kasbah Resources Limited 01R

Introduction

  1. The review Panel, Elizabeth Hallett, Rod Halstead and Michelle Jablko (sitting President), declined to conduct proceedings on a review application by Lois Lane Investments Pty Ltd, Bloom Financial Advice Pty Ltd and others1 in relation to the affairs of Kasbah Resources Limited. The review application concerned whether a placement to Pala Investments Limited contravened s6062 because of an association between Pala and Lion Selection Group Limited.

Kasbah Resources Limited

Introduction

  1. The Panel, Alex Cartel, Peter Day (sitting President) and Robert McKenzie, declined to conduct proceedings on an application by Lois Lane Investments Pty Ltd and Bloom Financial Advice Pty Ltd in relation to the affairs of Kasbah Resources Limited. The application concerned whether a placement to Pala Investments Limited would contravene s6061 because of an association between Pala and Lion Selection Group Limited.

Kasbah Resources Limited - Panel Receives Review Application

The Panel has received an application from Lois Lane Investments Pty Ltd, Bloom Financial Advice Pty Ltd and others seeking a review of the Panel's decision in Kasbah Resources Limited (see TP16/83).

A review Panel has not been appointed at this stage and no decision has been made whether to conduct proceedings. The Panel makes no comment on the merits of the application.

Subscribe to